SLC35C2
Solute carrier family 35 member C2
Also known as: bA394O2.1, C20orf5, CGI-15, OVCOV1, S35C2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NQQ7
- Gene
- SLC35C2
- Ensembl
- ENSG00000080189
- Chromosome
- 20
- Canonical length
- 365 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Golgi apparatus
OverviewNCBI Gene
This gene encodes a member of the triose-phosphate transporter protein family. This gene is regulated by oxygen tension, is induced in hypoxic trophoblast cells, and is overexpressed in ovarian cancer. Alternative splicing results in multiple transcript variants. A pseudogene of this gene has been defined on the X chromosome. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
365 residues, UniProt reviewed canonical sequence.
>Q9NQQ7|SLC35C2
1 MGRWALDVAF LWKAVLTLGL VLLYYCFSIG ITFYNKWLTK SFHFPLFMTM LHLAVIFLFS
61 ALSRALVQCS SHRARVVLSW ADYLRRVAPT ALATALDVGL SNWSFLYVTV SLYTMTKSSA
121 VLFILIFSLI FKLEELRAAL VLVVLLIAGG LFMFTYKSTQ FNVEGFALVL GASFIGGIRW
181 TLTQMLLQKA ELGLQNPIDT MFHLQPLMFL GLFPLFAVFE GLHLSTSEKI FRFQDTGLLL
241 RVLGSLFLGG ILAFGLGFSE FLLVSRTSSL TLSIAGIFKE VCTLLLAAHL LGDQISLLNW
301 LGFALCLSGI SLHVALKALH SRGDGGPKAL KGLGSSPDLE LLLRSSQREE GDNEEEEYFV
361 AQGQQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC35C2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 8
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- liver: 35 nTPM
- adrenal gland: 33 nTPM
- choroid plexus: 33 nTPM
- pancreas: 31 nTPM
- spleen: 30 nTPM
- skin: 29 nTPM
Single-cell type
- breast lactating cells: 144 nCPM
- cytotrophoblasts: 123 nCPM
- neutrophil progenitors: 108 nCPM
- epididymal principal cells: 103 nCPM
- syncytiotrophoblasts: 96 nCPM
- migrating cytotrophoblasts: 91 nCPM
Immune cell
- plasmacytoid DC: 73 nTPM
- eosinophil: 48 nTPM
- naive CD4 T-cell: 45 nTPM
- total PBMC: 44 nTPM
- basophil: 43 nTPM
- myeloid DC: 43 nTPM
Brain region
- thalamus: 23 nTPM
- midbrain: 23 nTPM
- amygdala: 22 nTPM
- medulla oblongata: 21 nTPM
- choroid plexus: 21 nTPM
- pons: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.87
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.23
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
OntologyGO
Biological processes
- negative regulation of gene expression
- positive regulation of Notch signaling pathway
- protein O-linked glycosylation via fucose
- UDP-glucose transmembrane transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC35C2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC35C2 as an antibody target. Whether an autoantibody or antibody against SLC35C2 could matter depends on whether native SLC35C2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC35C2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC35C2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...